West Pharmaceutical Services Other Long-Term Assets 2010-2025 | WST

West Pharmaceutical Services other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • West Pharmaceutical Services other long-term assets for the quarter ending March 31, 2025 were $0.070B, a 269.47% increase year-over-year.
  • West Pharmaceutical Services other long-term assets for 2024 were $0.074B, a 248.83% increase from 2023.
  • West Pharmaceutical Services other long-term assets for 2023 were $0.021B, a 44.53% decline from 2022.
  • West Pharmaceutical Services other long-term assets for 2022 were $0.038B, a 2.04% decline from 2021.
West Pharmaceutical Services Annual Other Long-Term Assets
(Millions of US $)
2024 $74
2023 $21
2022 $38
2021 $39
2020 $23
2019 $25
2018 $21
2017 $23
2016 $21
2015 $26
2014 $28
2013 $24
2012 $25
2011 $29
2010 $23
2009 $19
West Pharmaceutical Services Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $70
2024-12-31 $74
2024-09-30 $69
2024-06-30 $50
2024-03-31 $19
2023-12-31 $21
2023-09-30 $39
2023-06-30 $40
2023-03-31 $37
2022-12-31 $38
2022-09-30 $53
2022-06-30 $49
2022-03-31 $41
2021-12-31 $39
2021-09-30 $32
2021-06-30 $26
2021-03-31 $25
2020-12-31 $23
2020-09-30 $22
2020-06-30 $21
2020-03-31 $22
2019-12-31 $25
2019-09-30 $20
2019-06-30 $20
2019-03-31 $26
2018-12-31 $21
2018-09-30 $22
2018-06-30 $22
2018-03-31 $22
2017-12-31 $23
2017-09-30 $17
2017-06-30 $16
2017-03-31 $22
2016-12-31 $21
2016-09-30 $23
2016-06-30 $23
2016-03-31 $24
2015-12-31 $26
2015-09-30 $26
2015-06-30 $27
2015-03-31 $27
2014-12-31 $28
2014-09-30 $23
2014-06-30 $24
2014-03-31 $24
2013-12-31 $24
2013-09-30 $26
2013-06-30 $25
2013-03-31 $24
2012-12-31 $25
2012-09-30 $25
2012-06-30 $25
2012-03-31 $29
2011-12-31 $29
2011-09-30 $29
2011-06-30 $30
2011-03-31 $23
2010-12-31 $23
2010-09-30 $20
2010-06-30 $22
2010-03-31 $19
2009-12-31 $19
2009-09-30 $20
2009-06-30 $21
2009-03-31 $20
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.012B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.922B 21.71
Becton Dickinson (BDX) United States $49.623B 12.29
Cardinal Health (CAH) United States $36.592B 19.16
Straumann Holding AG (SAUHY) Switzerland $21.128B 0.00
Labcorp (LH) United States $20.200B 16.38
Cooper (COO) United States $15.873B 21.05
Align Technology (ALGN) United States $12.461B 24.74
Henry Schein (HSIC) United States $8.774B 15.05
Merit Medical Systems (MMSI) United States $5.703B 27.57
DENTSPLY SIRONA (XRAY) United States $3.155B 9.42
CONMED (CNMD) United States $1.776B 13.29
STAAR Surgical (STAA) United States $0.914B 0.00
Lifevantage (LFVN) United States $0.160B 16.53
Pro-Dex (PDEX) United States $0.145B 15.86